Premium
Dosing will be a key success factor in repurposing antivirals for COVID‐19
Author(s) -
Smith Patrick F.,
Dodds Michael,
Bentley Darren,
Yeo Karen,
Rayner Craig
Publication year - 2021
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/bcp.14314
Subject(s) - dosing , repurposing , drug repositioning , medicine , covid-19 , pharmacology , regimen , pharmacokinetics , lopinavir , intensive care medicine , therapeutic window , drug , biology , ecology , disease , infectious disease (medical specialty)